We are live on ! Find out more
WFI

West Family Investments Portfolio holdings

AUM $345M
1-Year Est. Return 46.29%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+46.29%
3 Year Est. Return
+116.17%
5 Year Est. Return
+113.18%
10 Year Est. Return
+254.99%
AUM
$287M
AUM Growth
-$6.75M
Cap. Flow
-$1.71M
Cap. Flow %
-0.6%
Top 10 Hldgs %
37.66%
Holding
318
New
25
Increased
63
Reduced
174
Closed
34

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.01M
2
SCHP icon
Schwab US TIPS ETF
SCHP
+$855K
3
BA icon
Boeing
BA
+$369K
4
TSN icon
Tyson Foods
TSN
+$354K
5
T icon
AT&T
T
+$353K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$469K
2
ELV icon
Elevance Health
ELV
+$428K
3
KLAC icon
KLA
KLAC
+$402K
4
MSFT icon
Microsoft
MSFT
+$368K
5
NKE icon
Nike
NKE
+$342K

Sector Composition

Rank Sector Weight
1 Technology 22.58%
2 Financials 10.43%
3 Healthcare 9.68%
4 Communication Services 6.71%
5 Consumer Discretionary 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
51
Home Depot
HD
$342B
$1.08M 0.37%
2,764
+77
+3% +$31.5K
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$133B
$1.07M 0.37%
2,652
-12
-0.5% -$5.56K
VZ icon
53
Verizon
VZ
$195B
$1.05M 0.36%
26,148
-1,536
-6% -$64.8K
MRSH
54
Marsh
MRSH
$90.1B
$1.04M 0.36%
4,878
-112
-2% -$24.8K
MCK icon
55
McKesson
MCK
$102B
$1.03M 0.36%
1,801
+141
+8% +$79K
CVS icon
56
CVS Health
CVS
$121B
$1.02M 0.36%
22,712
-2,280
-9% -$128K
KO icon
57
Coca-Cola
KO
$373B
$981K 0.34%
15,754
+2,076
+15% +$136K
NVS icon
58
Novartis
NVS
$290B
$974K 0.34%
10,009
+270
+3% +$28.8K
CRM icon
59
Salesforce
CRM
$158B
$941K 0.33%
2,816
-44
-2% -$14K
AZN icon
60
AstraZeneca
AZN
$246B
$922K 0.32%
7,034
-426
-6% -$59.6K
ORCL icon
61
Oracle
ORCL
$442B
$919K 0.32%
5,515
-163
-3% -$29K
BAC icon
62
Bank of America
BAC
$453B
$908K 0.32%
20,667
-298
-1% -$13.1K
ASML icon
63
ASML
ASML
$695B
$899K 0.31%
1,297
-8
-0.6% -$5.75K
NOW icon
64
ServiceNow
NOW
$129B
$893K 0.31%
4,210
+895
+27% +$181K
GILD icon
65
Gilead Sciences
GILD
$168B
$890K 0.31%
9,639
-165
-2% -$14.9K
UMC icon
66
United Microelectronic
UMC
$48.4B
$889K 0.31%
136,983
-4,678
-3% -$33.5K
T icon
67
AT&T
T
$166B
$864K 0.3%
37,961
+15,680
+70% +$353K
LIN icon
68
Linde
LIN
$221B
$844K 0.29%
2,015
-32
-2% -$14.6K
ED icon
69
Consolidated Edison
ED
$39.9B
$822K 0.29%
9,213
-125
-1% -$12.3K
IBM icon
70
IBM
IBM
$222B
$818K 0.28%
3,719
-44
-1% -$9.8K
REGN icon
71
Regeneron Pharmaceuticals
REGN
$82.2B
$810K 0.28%
1,137
-53
-4% -$44.5K
PGR icon
72
Progressive
PGR
$121B
$787K 0.27%
3,284
+6
+0.2% +$1.51K
SO icon
73
Southern Company
SO
$106B
$776K 0.27%
9,431
+45
+0.5% +$3.95K
COR icon
74
Cencora
COR
$60B
$771K 0.27%
3,433
+53
+2% +$12.5K
CB icon
75
Chubb
CB
$132B
$765K 0.27%
2,769
+6
+0.2% +$1.7K

Similar funds

West Family Investments's Q4 2024 Portfolio in Review

As of Q4 2024, West Family Investments held 318 positions worth $287M, down 2.3% from $294M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

West Family Investments's Q4 2024 filing shows 25 new, 63 increased, 174 reduced and 34 closed positions. Its largest new stake was Boeing: 2,349 shares worth $416K. The largest sale was Pfizer, an estimated $469K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • West Family Investments's largest Q4 2024 buy was Boeing: 2,349 shares worth $416K.
  • West Family Investments added most to iShares 20+ Year Treasury Bond ETF in Q4 2024, an estimated $2.01M increase.
  • West Family Investments's biggest Q4 2024 reduction was Microsoft, cutting an estimated $368K.
  • West Family Investments fully exited Pfizer in Q4 2024, selling an estimated $469K.
  • West Family Investments's ten largest holdings make up 38% of its $287M portfolio in Q4 2024.
  • West Family Investments opened 25 new positions and closed 34 in Q4 2024.
  • West Family Investments's portfolio value fell 2.3% quarter-over-quarter to $287M.

Based on West Family Investments's 13F filing for Q4 2024, filed 7 Feb 2025.